Gabapentin, a pain reliever and anti-seizure medication, shows potential in extending glioblastoma patient survival, according to a study by Mass General Brigham researchers.

A new brain cancer study from Mass General Brigham suggests that gabapentin, a pain-relieving drug, may extend survival in glioblastoma patients, showing promising results.

A study shows a non-opioid pain reliever blocks pain at its source -- calming specific nerve signals that send pain messages to the brain. In mice, the compound SBI-810 eased pain from surgery ...

It also outperformed gabapentin, a common drug for nerve pain, and didn't cause sedation or memory problems, which are often seen with gabapentin.

SBI-810 effectively relieved pain from surgical incisions, bone fractures, and nerve injuries better than some existing painkillers. When injected in mice, it reduced signs of spontaneous ...

A study in Cell shows a non-opioid pain reliever developed by Duke University School of Medicine blocks pain at its source—calming specific nerve signals that send pain messages to the brain.

Toxin-related or medication-induced nerve pain; Post-injury nerve complications …the guide provides adaptable recommendations that can be customized to various lifestyle needs. Disclaimer: Individual ...

Nerve discomfort impacts millions of individuals worldwide, often manifesting as tingling, burning, or numbness in the hands, feet, or extremities. While prescription drugs are commonly prescribed ...

Gabapentin is often used long-term to manage chronic nerve pain, especially when combined with other treatments. Although it hasn’t been studied beyond six months, it’s generally considered safe for ...

The variety of non-hormonal treatments for hot flashes includes some antidepressants and gabapentin, typically used for nerve pain. A newer drug, Veozah, was approved by the FDA in 2023 to treat ...

The variety of non-hormonal treatments for hot flashes includes some antidepressants and gabapentin, typically used for nerve pain. A newer drug, Veozah, was approved by the FDA in 2023 to treat ...

Gabapentinoids include gabapentin and pregabalin, which often are used off-label for chronic pain. Gabapentinoid use did not appear to be linked directly with self-harm risk, a population-based ...